Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion (Q42253318)
Jump to navigation
Jump to search
scientific article published on 23 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion |
scientific article published on 23 April 2012 |
Statements
1 reference
Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion (English)
1 reference
1 reference
S Wei
1 reference
X Chen
1 reference
K McGraw
1 reference
L Zhang
1 reference
R Komrokji
1 reference
J Clark
1 reference
G Caceres
1 reference
D Billingsley
1 reference
L Sokol
1 reference
J Lancet
1 reference
N Fortenbery
1 reference
J Zhou
1 reference
D Sallman
1 reference
H Wang
1 reference
P K Epling-Burnette
1 reference
J Djeu
1 reference
M Sekeres
1 reference
J P Maciejewski
1 reference
A List
1 reference
1 reference
1 reference
Identifiers
1 reference